Timing of DAS28 in infliximab therapy.
作者信息
Armstrong D J, Bruce I N
出版信息
Rheumatology (Oxford). 2005 Sep;44(9):1203-4; author reply 1204. doi: 10.1093/rheumatology/keh681. Epub 2005 May 3.
PMID:15870143
Abstract
摘要
相似文献
1
Timing of DAS28 in infliximab therapy.
Rheumatology (Oxford). 2005 Sep;44(9):1203-4; author reply 1204. doi: 10.1093/rheumatology/keh681. Epub 2005 May 3.
2
Shortening infusion times for infliximab administration.
Rheumatology (Oxford). 2006 Apr;45(4):485-6. doi: 10.1093/rheumatology/kei247. Epub 2005 Dec 13.
3
Infusion reaction to infliximab in a patient with rheumatoid arthritis after discontinuation over 1 year and readministration.
J Rheumatol. 2008 Sep;35(9):1896-7; author reply 1897.
4
How to dose infliximab in rheumatoid arthritis: new data on a serious issue.
Ann Rheum Dis. 2009 Aug;68(8):1237-9. doi: 10.1136/ard.2009.111682.
5
Increasing the infliximab dose in rheumatoid arthritis patients: a randomised, double blind study failed to confirm its efficacy.
Ann Rheum Dis. 2009 Aug;68(8):1285-9. doi: 10.1136/ard.2008.090860. Epub 2009 Apr 6.
6
Sustained effect after lowering high-dose infliximab in patients with rheumatoid arthritis: a prospective dose titration study.
Ann Rheum Dis. 2008 Dec;67(12):1697-701. doi: 10.1136/ard.2007.083683. Epub 2008 Jan 31.
7
Therapy of patients with rheumatoid arthritis: outcome of infliximab failures switched to etanercept.
Arthritis Rheum. 2007 Apr 15;57(3):448-53. doi: 10.1002/art.22617.
8
Use of rituximab for the treatment of rheumatoid arthritis: the Latin American context.
Rheumatology (Oxford). 2008 Jul;47(7):1097-9. doi: 10.1093/rheumatology/ken015a. Epub 2008 May 7.
9
DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment.
Arthritis Res Ther. 2005;7(5):R1063-71. doi: 10.1186/ar1787. Epub 2005 Jul 8.
10
Long-term treatment of rheumatoid arthritis with tumour necrosis factor alpha blockade: outcome of ceasing and restarting biologicals.
Rheumatology (Oxford). 2004 Feb;43(2):243-4. doi: 10.1093/rheumatology/keg454.
Zotero 插件